Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.


Değertekin B., Demir M., Akarca U. S., Kani H. T., Üçbilek E., Yıldırım E., ...Daha Fazla

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.31, sa.12, ss.883-893, 2020 (SCI-Expanded) identifier identifier